Crossmark

Preoperative chemotherapy combined with para-aortic lymph node dissection has clinical value in the treatment of gastric cancer with para-aortic lymph node metastases

Crossref DOI link: https://doi.org/10.1186/s12893-022-01844-0

Published Online: 2022-11-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Pengcheng

Hu, Can

Wang, Yi

Bao, Zhehan

Zhang, Ruolan

Cao, Mengxuan

Zhang, Yanqiang

Cheng, Xiangdong

Xu, Zhiyuan
Funding

Funding for this research was provided by:

Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer (JBZX-202006)

National Natural Science Foundation of China (81973634)

Program of Zhejiang Provincial TCM Sci-tech Plan (2019ZZ010)
License Information

Text and Data Mining valid from 2022-11-20

Version of Record valid from 2022-11-20
More Information

Article History

Received: 27 May 2022

Accepted: 8 November 2022

First Online: 20 November 2022

Declarations

:

: This study was approved by the ethics committee of the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) (No. IRB-2020-300). Informed consent from the patients was waived by the ethics committee of the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) (No. IRB-2020-300) because of the retrospective nature of this study, and conformed to the tenets of the Declaration of Helsinki (as revised in 2013).

: None.

: The authors declare have no conflict of interest.

Document is current

Any future updates will be listed below